APA Citation

Tate, S. (2005). Development of a new mutation in EGFR leads to drug resistance in non-small cell lung cancer. BMJ Group.

Chicago Style Citation

Tate, S. Development of a New Mutation in EGFR Leads to Drug Resistance in Non-small Cell Lung Cancer. BMJ Group, 2005.

MLA Citation

Tate, S. Development of a New Mutation in EGFR Leads to Drug Resistance in Non-small Cell Lung Cancer. BMJ Group, 2005.

Warning: These citations may not always be 100% accurate.